Molecular Partners Highlights Upcoming Oncology Portfolio Presentations in December

NEXT STORY
iOnctura Presents Positive Clinical Data At ESMO-IO Supporting Advancement of IOA-289, a Novel Autotaxin Inhibitor, Into Phase Ib Pancreatic Cancer Studies
PREV STORY
Kinross announces acquisition of Great Bear Resources
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Blood Collection Market to reach US $7.36 billion by 2028 – Global Industry Analysis on Procedure, Application, Product Launches, Technological Innovations, Geographic Expansions and Future Prospect: Adroit Market Research

author_avatar
NASDAQ Market News

APEIRON, the Medical University of Vienna and the Institute of Molecular Biotechnology Sign Licensing Agreement for a New Checkpoint Inhibitor

APEIRON strengthens its proprietary Cbl-b portfolio with cutting edge immunotherapy technology developed at IMBA ...

author_avatar
NASDAQ Market News

Molecular Diagnostics Devices And Equipment Market Faces Great Demand Due To Increased Testing During The COVID-19 Pandemic

author_avatar
NASDAQ Market News